Regimens for the therapeutic or prophylactic administration of pulmonary surfactant to infants exhibiting or at risk of developing bronchopulmonary dysplasia are disclosed.

 
Web www.patentalert.com

< Histone H2A peptide derivatives and uses thereof

> Angiogenically effective unit dose of FGF-2 and method of use

> Methods and compositions for the treatment of peripheral artery disease
~ 00522